The National Institute of Environmental Health Sciences (NIEHS) intends to negotiate on a sole source basis with Covance Research Products, pursuant to 41 U.S.C.253(c)(1)--Only one responsible source and no other supplies or services will satisfy agency requirements. This procurement is for the purchase of animal polyclonal and monoclonal (hybridoma) antibody services. Services include the use of hybridoma cell lines developed by Covance Research Products. The hybridoma development project involves four phases: Immunization, Fusion, Cloning, and Stabilization of Hybridoma. Animal antibody production services are required from Covance to maintain consistency and continuity in existing research projects. This will be awarded as a Term Purchase Order for a period of approximately 10 months. Any firm believing itself capable of providing these services may respond by submitting a written narrative statement of capability within 10 days of date of notice to Dee Lunney at the above address for consideration by the agency. Response must include detailed technical information and other technical literature demonstrating the ability to meet these requirements. Responses shall also include itemized pricing that is sufficient to make a determination that competition is feasible. If no affirmative responses are received within 10 days of this notice to determine whether a qualified source is more advantageous to the Government, an order will be placed with Covance Research Products. The NAICS Code/Size is 541690/$6.5M. This procurement is to be processed using Simplified Acquisition Procedures in conjunction with FAR Part 12, Acquisition of Commercial Items and is not expected to exceed the Simplified Acquisition threshold of $100,000. There is no solicitation package. For any questions regarding this solicitation, please contact Dee Lunney via email [email protected].*****

Bid Protests Not Available